Abstract:BACKGROUND Lateral lymph node metastasis is one of the leading causes of local recurrence in patients with advanced mid or low rectal cancer. Neoadjuvant chemoradiotherapy (NCRT) can effectively reduce the postoperative recurrence rate; thus, NCRT with total mesorectal excision (TME) is the most widely accepted standard of care for rectal cancer. The addition of lateral lymph node dissection (LLND) after NCRT remains a controversial topic. AIM To investigate the surgical outcomes of TME plus LLND, and the possible risk factors for lateral lymph node metastasis after NCRT. METHODS This retrospective study reviewed 89 consecutive patients with clinical stage II-III mid or low rectal cancer who underwent TME and LLND from June 2016 to October 2018. In the NCRT group, TME plus LLND was performed in patients with short axis (SA) of the lateral lymph node greater than 5 mm. In the non-NCRT group, TME plus LLND was performed in patients with SA of the lateral lymph node greater than 10 mm. Data regarding patient demographics, clinical workup, surgical procedure, complications, and outcomes were collected. Multivariate logistic regression analysis was performed to evaluate the possible risk factors for lateral lymph node metastasis in NCRT patients. RESULTS LLN metastasis was pathologically confirmed in 35 patients (39.3%): 26 (41.3%) in the NCRT group and 9 (34.6%) in the non-NCRT group. The most common site of metastasis was around the obturator nerve (21/35) followed by the internal iliac artery region (12/35). In the NCRT patients, 46% of patients with SA of LLN greater than 7 mm were positive. The postoperative 30-d mortality rate was 0%. Two (2.2%) patients suffered from lateral local recurrence in the 2-year follow up. Multivariate analysis showed that cT4 stage (odds ratio [OR] = 5.124, 95% confidence interval [CI]: 1.419-18.508; P = 0.013), poor differentiation type (OR = 4.014, 95%CI: 1.038-15.520; P = 0.044), and SA ≥ 7 mm (OR = 7.539, 95%CI: 1.487-38.214; P = 0.015) were statistically significant risk factors associated with LLN metastasis. CONCLUSION NCRT is not sufficient as a stand-alone therapy to eradicate LLN metastasis in lower rectal cancer patients and surgeons should consider performing selective LLND in patients with greater LLN SA diameter, poorer histological differentiation, or advanced T stage. Selective LLND for NCRT patients can have a favorable oncological outcome.

Feasibility, Indications and Prognostic Significance of Selective Dissection after Preoperative Chemoradiotherapy in Middle/Low Rectal Cancer with Clinical Suspected Lateral Pelvic Lymph Node Involvement: Results of the Multicenter Lateral Node Study in China

Feasibility, Indications, and Prognostic Significance of Selective Lateral Pelvic Lymph Node Dissection after Preoperative Chemoradiotherapy in Middle/Low Rectal Cancer: Results of a Multicenter Lateral Node Study in China.

Effective dissecting range and prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: Results of a large multicenter lateral node collaborative group in China

Can neoadjuvant chemoradiotherapy before lateral pelvic lymph node dissection improve local control and prognosis in rectal cancer patients with clinically suspected lateral lymph node metastasis? A multicenter lateral node study in China

Short- and Long-Term Outcomes of Laparoscopic Versus Open Selective Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-Low Rectal Cancer: Results of a Multicentre Lateral Node Study in China.

Short‐term and Long‐term Outcomes of Laparoscopic Versus Open Selective Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle‐low Rectal Cancer: Results of a Multicenter Lateral Node Study in China

The Value of Lymph Node Ratio in the Prediction of Rectal Cancer Patient Survival after Preoperative Chemoradiotherapy.

Risk Factors and Prognostic Significance of Postoperative Complications Following Lateral Pelvic Lymph Node Dissection for Rectal Cancer: Results of the Multicenter Lateral Node Study in China.

Laparoscopic lateral pelvic lymph node dissection for patients with low rectal cancer after neoadjuvant chemoradiation

Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer

Indications and Oncological Outcomes of Selective Dissection for Clinically Suspected Lateral Lymph Node Metastasis in Patients with Rectal Cancer Based on Pretreatment Imaging

Feasibility and Safety of Lateral Pelvic Lymph Node Dissection for Elderly Patients with Middle-Low Rectal Cancer: Results of a Large Multicenter Lateral Node Collaborative Group Study in China

Can chemoradiation allow for omission of lateral pelvic node dissection for locally advanced rectal cancer?

The role of lateral pelvic lymph node dissection in advanced rectal cancer: a review of current evidence and outcomes

Identification of lateral pelvic nodes without metastasis in patients with rectal cancer treated with preoperative chemoradiotherapy or chemotherapy based on magnetic resonance imaging

Is Laparoscopic Selective Lateral Lymph Node Dissection for Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy Safe?

Short-term outcomes of 47 selective laparoscopic lymph node dissection for rectal cancer: A retrospective study

What is the Role of Lateral Lymph Node Dissection in Rectal Cancer Patients with Clinically Suspected Lateral Lymph Node Metastasis after Preoperative Chemoradiotherapy? A Meta-Analysis and Systematic Review

Optimization of treatment strategies based on preoperative imaging features and local recurrence areas for locally advanced lower rectal cancer after lateral pelvic lymph node dissection

Lateral pelvic lymph node dissection after neoadjuvant chemo-radiation for preoperative enlarged lateral nodes in advanced low rectal cancer: study protocol for a randomized controlled trial

Prognostic value of lateral lymph node metastasis in pretreatment MRI for rectal cancer in patients undergoing neoadjuvant chemoradiation followed by surgical resection without lateral lymph node dissection: A systemic review and meta-analysis